Literature DB >> 7850201

Extrachromosomal resistance in gram-negative organisms: the evolution of beta-lactamase.

G A Jacoby1.   

Abstract

beta-Lactamases are the major defense used by bacteria to overcome the effects of penicillins, cephalosporins and related beta-lactam antibiotics. In the antibiotic era, the enzymes have evolved to become more prevalent, to appear in new hosts, to be expressed at higher levels, to be acquired by plasmids and to change catalytic properties to increase affinity for what were meant to be nonhydrolysable substrates or to reduce affinity for beta-lactamase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7850201     DOI: 10.1016/0966-842x(94)90611-4

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  16 in total

1.  Identification of residues critical for metallo-beta-lactamase function by codon randomization and selection.

Authors:  I C Materon; T Palzkill
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

Review 2.  Catalytic properties of class A beta-lactamases: efficiency and diversity.

Authors:  A Matagne; J Lamotte-Brasseur; J M Frère
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

3.  Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae.

Authors:  K E Conrath; M Lauwereys; M Galleni; A Matagne; J M Frère; J Kinne; L Wyns; S Muyldermans
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

4.  Kinetic study of two novel enantiomeric tricyclic beta-lactams which efficiently inactivate class C beta-lactamases.

Authors:  M Vilar; M Galleni; T Solmajer; B Turk; J M Frère; A Matagne
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

5.  Daughter cell separation by penicillin-binding proteins and peptidoglycan amidases in Escherichia coli.

Authors:  Richa Priyadarshini; David L Popham; Kevin D Young
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

6.  Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type beta-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC beta-lactamase.

Authors:  S W Wu; K Dornbusch; G Kronvall; M Norgren
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

7.  Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals.

Authors:  M Quinteros; M Radice; N Gardella; M M Rodriguez; N Costa; D Korbenfeld; E Couto; G Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  Antimicrobial resistance genes in enterotoxigenic Escherichia coli O149:K91 isolates obtained over a 23-year period from pigs.

Authors:  Christine Maynard; John M Fairbrother; Sadjia Bekal; François Sanschagrin; Roger C Levesque; Roland Brousseau; Luke Masson; Serge Larivière; Josée Harel
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

9.  Associations between antimicrobial resistance genes in fecal generic Escherichia coli isolates from cow-calf herds in western Canada.

Authors:  Sheryl P Gow; Cheryl L Waldner; Josee Harel; Patrick Boerlin
Journal:  Appl Environ Microbiol       Date:  2008-04-18       Impact factor: 4.792

10.  AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis.

Authors:  Melissa A Visalli; Ellen Murphy; Steven J Projan; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.